{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:58Z","timestamp":1790456098824,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10620-023-08085-y","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:02:27Z","timestamp":1695283347000},"page":"4485-4498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study"],"prefix":"10.1007","volume":"68","author":[{"given":"Umang","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritik M.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K. J.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B. B.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnik","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manas","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabreena","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwesh","family":"Bharadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuman","family":"Elhence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivanand","family":"Gamanagatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajna","family":"Anirvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arka","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-437X","authenticated-orcid":false,"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"6","key":"8085_CR1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/hep4.1689","volume":"5","author":"AS Barritt","year":"2021","unstructured":"Barritt AS, Watkins S, Gitlin N, Klein S, Lok AS, Loomba R et al. Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study. Hepatol Commun. 2021;5:938\u2013946.","journal-title":"Hepatol Commun."},{"issue":"1","key":"8085_CR2","first-page":"76","volume":"8","author":"R Kumar","year":"2020","unstructured":"Kumar R, Priyadarshi RN, Anand U. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. J Clin Transl Hepatol. 2020 Mar 28;8:76\u201386.","journal-title":"J Clin Transl Hepatol."},{"key":"8085_CR3","doi-asserted-by":"crossref","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, et al. Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis. J Clin Exp Hepatol. 2022 May;12:818\u201329.","DOI":"10.1016\/j.jceh.2021.11.010"},{"issue":"9","key":"8085_CR4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022 Sep;7:851\u2013861.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"1","key":"8085_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ajg.2014.134","volume":"110","author":"P Blais","year":"2015","unstructured":"Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015 Jan;110:10\u201314.","journal-title":"Am J Gastroenterol."},{"issue":"Suppl 1","key":"8085_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/liv.14347","volume":"40","author":"L Castera","year":"2020","unstructured":"Castera L. Non-invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics. Liver International. 2020 Feb;40:77\u201381.","journal-title":"Liver International."},{"issue":"2","key":"8085_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. J Hepatol. 2018 Feb;68:305\u2013315.","journal-title":"J Hepatol."},{"issue":"4","key":"8085_CR8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4254\/wjh.v7.i4.638","volume":"7","author":"M Papagianni","year":"2015","unstructured":"Papagianni M, Sofogianni A, Tziomalos K. Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World J Hepatol. 2015 Apr 8;7:638\u2013648.","journal-title":"World J Hepatol."},{"issue":"4","key":"8085_CR9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007 Apr;45:846\u2013854.","journal-title":"Hepatology."},{"issue":"9","key":"8085_CR10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","volume":"46","author":"W Sun","year":"2016","unstructured":"Sun W, Cui H, Li N, Wei Y, Lai S, Yang Y et al. Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study. Hepatol Res. 2016 Aug;46:862\u2013870.","journal-title":"Hepatol Res."},{"issue":"6","key":"8085_CR11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","volume":"63","author":"C Cassinotto","year":"2016","unstructured":"Cassinotto C, Boursier J, de L\u00e9dinghen V, Lebigot J, Lapuyade B, Cales P et al. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. 2016 Jun;63:1817\u20131827.","journal-title":"Hepatology."},{"issue":"6","key":"8085_CR12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012 Jun;55:2005\u20132023.","journal-title":"Hepatology."},{"issue":"6","key":"8085_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41:1313\u20131321.","journal-title":"Hepatology."},{"issue":"10290","key":"8085_CR14","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021 Jun 5;397:2212\u20132224.","journal-title":"Lancet."},{"issue":"1","key":"8085_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jceh.2018.02.010","volume":"9","author":"G Rout","year":"2019","unstructured":"Rout G, Kedia S, Nayak B, Yadav R, Das P, Acharya SK et al. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. J Clin Exp Hepatol. 2019 Feb;9:13\u201321.","journal-title":"J Clin Exp Hepatol."},{"issue":"6","key":"8085_CR16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006 Jun;43:1317\u20131325.","journal-title":"Hepatology."},{"issue":"10","key":"8085_CR17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008 Oct 1;57:1441\u20131447.","journal-title":"Gut."},{"issue":"1","key":"8085_CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/ceh.2021.104543","volume":"7","author":"R Catanzaro","year":"2021","unstructured":"Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol. 2021 Mar;7:111\u2013116.","journal-title":"Clin Exp Hepatol."},{"issue":"1","key":"8085_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","volume":"11","author":"G Shiha","year":"2017","unstructured":"Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017 Jan;11:1\u201330.","journal-title":"Hepatol Int."},{"issue":"3","key":"8085_CR20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver","year":"2021","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021 Sep;75:659\u2013689.","journal-title":"J Hepatol."},{"key":"8085_CR21","doi-asserted-by":"crossref","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases: Hepatology, Vol. XX, No. X, 2017. Hepatology. 2018 Jan;67:328\u201357.","DOI":"10.1002\/hep.29367"},{"key":"8085_CR22","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Foucquier J, Younossi ZM, Harrison SA, Newsome PN, Chan WK, et al. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores. Journal of Hepatology. 2023 Feb;78(2):247\u201359.","DOI":"10.1016\/j.jhep.2022.10.034"},{"issue":"4","key":"8085_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan WK et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020 Apr 1;5:362\u2013373.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"5","key":"8085_CR24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022 May 1;71:1006\u20131019.","journal-title":"Gut."},{"issue":"10","key":"8085_CR25","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009 Oct;7:1104\u20131112.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"12","key":"8085_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"5","author":"Y Sumida","year":"2012","unstructured":"Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012 Jan;5:2.","journal-title":"BMC Gastroenterol."},{"issue":"9","key":"8085_CR27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010 Sep;59:1265\u20131269.","journal-title":"Gut."},{"key":"8085_CR28","unstructured":"Wong VWS, Tak WY, Goh GBB, Cheng PN, Lawitz EJ, Younossi ZM, et al. Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials. Clin Gastroenterol Hepatol. 2022 Jan 22;"},{"issue":"5","key":"8085_CR29","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1007\/s11695-020-04996-1","volume":"31","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani SA, Golabi P, Paik JM, Lam B, Moazez AH, Elariny HA et al. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obes Surg. 2021;31:2002\u20132010.","journal-title":"Obes Surg."},{"issue":"2","key":"8085_CR30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/flgastro-2017-100865","volume":"9","author":"S De Silva","year":"2018","unstructured":"De Silva S, Li W, Kemos P, Brindley JH, Mecci J, Samsuddin S et al. Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent. Frontline Gastroenterol. 2018 Apr;9:115\u2013121.","journal-title":"Frontline Gastroenterol."},{"issue":"8","key":"8085_CR31","volume":"13","author":"B Kumari","year":"2021","unstructured":"Kumari B, Kumar R, Sharma S, Banerjee A, Kumar V, Kumar P et al. Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease. Cureus. 2021 Aug;13:e17622.","journal-title":"Cureus."},{"issue":"6","key":"8085_CR32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.aohep.2020.08.066","volume":"19","author":"R Zambrano-Huailla","year":"2020","unstructured":"Zambrano-Huailla R, Guedes L, Stefano JT, de Souza AAA, Marciano S, Yvamoto E et al. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population. Ann Hepatol. 2020 Nov 1;19:622\u2013626.","journal-title":"Ann Hepatol."},{"issue":"8","key":"8085_CR33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","volume":"43","author":"G Musso","year":"2011","unstructured":"Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011 Dec;43:617\u2013649.","journal-title":"Ann Med."},{"issue":"7","key":"8085_CR34","first-page":"1682","volume":"103","author":"VWS Wong","year":"2008","unstructured":"Wong VWS, Wong GLH, Chim AML, Tse AML, Tsang SWC, Hui AY et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol. 2008 Jul;103:1682\u20131688.","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"8085_CR35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M et al. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis. Am J Gastroenterol. 2017 May;112:740\u2013751.","journal-title":"Am J Gastroenterol."},{"issue":"01","key":"8085_CR36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0029-1214155","volume":"35","author":"G Banfi","year":"2009","unstructured":"Banfi G, Fabbro MD. Biological Variation in Tests of Hemostasis. Semin Thromb Hemost. 2009 Feb;35:119\u2013126.","journal-title":"Semin Thromb Hemost."},{"issue":"9","key":"8085_CR37","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2017.05.002","volume":"15","author":"R Hernaez","year":"2017","unstructured":"Hernaez R, Thrift AP. High Negative Predictive Value, Low Prevalence, and Spectrum Effect: Caution in the Interpretation. Clin Gastroenterol Hepatol. 2017 Sep;15:1355\u20131358.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"8085_CR38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","volume":"1","author":"K Hallsworth","year":"2019","unstructured":"Hallsworth K, Adams LA. Lifestyle modification in NAFLD\/NASH: Facts and figures. JHEP Rep. 2019 Nov 5;1:468\u2013479.","journal-title":"JHEP Rep."},{"issue":"9","key":"8085_CR39","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.cgh.2017.02.031","volume":"15","author":"SE Mahady","year":"2017","unstructured":"Mahady SE, Macaskill P, Craig JC, Wong GLH, Chu WCW, Chan HLY et al. Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis. Clin Gastroenterol Hepatol. 2017 Sep;15:1453-1460.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8085_CR40","doi-asserted-by":"crossref","unstructured":"Cao Y tian, Xiang L lan, Qi F, Zhang Y juan, Chen Y, Zhou X qiao. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. eClinicalMedicine. 2022 Sep;51:101547.","DOI":"10.1016\/j.eclinm.2022.101547"},{"issue":"11","key":"8085_CR41","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","volume":"68","author":"VWS Wong","year":"2019","unstructured":"Wong VWS, Irles M, Wong GLH, Shili S, Chan AWH, Merrouche W et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut. 2019 Nov;68:2057\u20132064.","journal-title":"Gut."},{"issue":"6","key":"8085_CR42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2017.01.003","volume":"66","author":"J Boursier","year":"2017","unstructured":"Boursier J, de Ledinghen V, Leroy V, Anty R, Francque S, Salmon D et al. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis. J Hepatol. 2017 Jun;66:1158\u20131165.","journal-title":"J Hepatol."},{"issue":"1","key":"8085_CR43","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.24654","volume":"55","author":"J Boursier","year":"2012","unstructured":"Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F et al. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive. Hepatology. 2012;55:58\u201367.","journal-title":"Hepatology."},{"issue":"2","key":"8085_CR44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","volume":"71","author":"A Srivastava","year":"2019","unstructured":"Srivastava A, Gailer R, Tanwar S, Trembling P, Parkes J, Rodger A et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol. 2019 Aug;71:371\u2013378.","journal-title":"J Hepatol."},{"issue":"2","key":"8085_CR45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","volume":"71","author":"J Boursier","year":"2019","unstructured":"Boursier J, Guillaume M, Leroy V, Irl\u00e8s M, Roux M, Lannes A et al. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. J Hepatol. 2019 Aug 1;71:389\u2013396.","journal-title":"J Hepatol."},{"issue":"12","key":"8085_CR46","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.cgh.2019.03.006","volume":"17","author":"WK Chan","year":"2019","unstructured":"Chan WK, Treeprasertsuk S, Goh GBB, Fan JG, Song MJ, Charatcharoenwitthaya P et al. Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis. Clin Gastroenterol Hepatol. 2019 Nov;17:2570-2580.e37.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"8085_CR47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251741","volume":"16","author":"SE Congly","year":"2021","unstructured":"Congly SE, Shaheen AA, Swain MG. Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting. PLOS ONE. 2021 May 21;16:e0251741.","journal-title":"PLOS ONE."},{"issue":"1","key":"8085_CR48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1756283X15611581","volume":"9","author":"ME Rinella","year":"2016","unstructured":"Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH et al. Practice patterns in NAFLD and NASH: real life differs from published guidelines. Ther Adv Gastroenterol. 2016 Jan;9:4\u201312.","journal-title":"Ther Adv Gastroenterol."},{"issue":"5","key":"8085_CR49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2020.06.007","volume":"73","author":"H Hagstr\u00f6m","year":"2020","unstructured":"Hagstr\u00f6m H, Talb\u00e4ck M, Andreasson A, Walldius G, Hammar N. Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J. Hepatol. 2020 Nov;73(5):1023\u20131029.","journal-title":"J. Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08085-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08085-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T14:06:45Z","timestamp":1699538805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08085-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8085"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08085-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there are no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}